Cargando…

Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review

Aspergillus fracture-related infection (FRI) is a rare, but severe complication in trauma surgery. The optimal antifungal treatment for Aspergillus osteomyelitis, including FRI, has not been established yet, as only cases have been documented and data on bone penetration of antifungal drugs are scar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mertens, Beatrijs, Van Daele, Ruth, Depypere, Melissa, Lagrou, Katrien, Debaveye, Yves, Wauters, Joost, Nijs, Stefaan, Metsemakers, Willem-Jan, Spriet, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944859/ https://www.ncbi.nlm.nih.gov/pubmed/35326807 http://dx.doi.org/10.3390/antibiotics11030344

Ejemplares similares

The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation
por: Mertens, Beatrijs, et al.
Publicado: (2022)

Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review
por: Mertens, Beatrijs, et al.
Publicado: (2023)

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
por: Jansen, Anouk M. E., et al.
Publicado: (2023)

Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients
por: Van Daele, Ruth, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study
por: Gijsen, Matthias, et al.
Publicado: (2021)

Therapeutic efficacy of isavuconazole in experimental Aspergillus fumigatus endophthalmitis
por: Guest, John, et al.
Publicado: (2017)

Bacteriophage Application for Difficult-To-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol
por: Onsea, Jolien, et al.
Publicado: (2019)

Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid
por: Van Daele, Ruth, et al.
Publicado: (2021)

Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function
por: Gijsen, Matthias, et al.
Publicado: (2022)

Segmental Bone Loss of the Clavicle due to Fracture-Related Infection: A Multidisciplinary Challenge
por: Goormans, Femke, et al.
Publicado: (2019)

In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates
por: Buil, J B, et al.
Publicado: (2020)

The Microbiological Etiology of Fracture-Related Infection
por: Depypere, Melissa, et al.
Publicado: (2022)

2114. Evaluation of Isavuconazole Activity against Non-fumigatus Aspergillus and cryptic Aspergillus species Causing Invasive Infections Worldwide
por: Carvalhaes, Cecilia G, et al.
Publicado: (2023)

Aspergillus fumigatus Detection and Risk Factors in Patients with COPD–Bronchiectasis Overlap
por: Everaerts, Stephanie, et al.
Publicado: (2018)

First Investigative Study of Azole-Resistant Aspergillus fumigatus in the Environment in Burkina Faso
por: Yerbanga, Isidore W., et al.
Publicado: (2021)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis
por: Gijsen, Matthias, et al.
Publicado: (2021)

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
por: Everaerts, Stephanie, et al.
Publicado: (2017)

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations
por: Pfaller, Michael A., et al.
Publicado: (2023)

Hmg1 Gene Mutation Prevalence in Triazole-Resistant Aspergillus fumigatus Clinical Isolates
por: Resendiz-Sharpe, Agustin, et al.
Publicado: (2020)

Meropenem Stability in Human Plasma at −20 °C: Detailed Assessment of Degradation
por: Gijsen, Matthias, et al.
Publicado: (2021)

Triazole-Resistance in Environmental Aspergillus fumigatus in Latin American and African Countries
por: Resendiz-Sharpe, Agustin, et al.
Publicado: (2021)

Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates
por: Arendrup, Maiken Cavling, et al.
Publicado: (2016)

868. In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations
por: Pfaller, Michael A, et al.
Publicado: (2022)

Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

Quantitative PCR Effectively Quantifies Triazole-Susceptible and Triazole-Resistant Aspergillus fumigatus in Mixed Infections
por: Resendiz-Sharpe, Agustin, et al.
Publicado: (2022)

2113. Evaluation of Isavuconazole Activity against Aspergillus fumigatus Causing Invasive Infections Worldwide Using the New CLSI Clinical Breakpoints
por: Carvalhaes, Cecilia G, et al.
Publicado: (2023)

Role of Hydrophobins in Aspergillus fumigatus
por: Valsecchi, Isabel, et al.
Publicado: (2017)

Analytical Comparison of In Vitro-Spiked Human Serum and Plasma for PCR-Based Detection of Aspergillus fumigatus DNA: a Study by the European Aspergillus PCR Initiative
por: Loeffler, Juergen, et al.
Publicado: (2015)

Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
por: Feys, Simon, et al.
Publicado: (2023)

Economics of open tibial fractures: the pivotal role of length-of-stay and infection
por: Hoekstra, Harm, et al.
Publicado: (2017)

Colistin and Isavuconazole Interact Synergistically In Vitro against Aspergillus nidulans and Aspergillus niger
por: Schwarz, Patrick, et al.
Publicado: (2020)

Powerful and Real-Time Quantification of Antifungal Efficacy against Triazole-Resistant and -Susceptible Aspergillus fumigatus Infections in Galleria mellonella by Longitudinal Bioluminescence Imaging
por: Vanhoffelen, Eliane, et al.
Publicado: (2023)

Pulmonary Aspergillosis in Humboldt Penguins—Susceptibility Patterns and Molecular Epidemiology of Clinical and Environmental Aspergillus fumigatus Isolates from a Belgian Zoo, 2017–2022
por: Debergh, Hanne, et al.
Publicado: (2023)

Azole-Resistant Aspergillus fumigatus, Iran
por: Seyedmousavi, Seyedmojtaba, et al.
Publicado: (2013)

Discovery and characterization of novel Aspergillus fumigatus mycoviruses
por: Zoll, Jan, et al.
Publicado: (2018)

Aspergillus fumigatus in Poultry
por: Arné, Pascal, et al.
Publicado: (2011)

Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)
por: Onsea, Jolien, et al.
Publicado: (2021)

Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus
por: Doni, Andrea, et al.
Publicado: (2021)

Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program
por: Thijs, Lore, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bg6p5plm3pjje4l7pempb8q9oq